ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares closed down about 13% after the company announced a proposed public offering of its common stock yesterday.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous …
MannKind Corporation (NASDAQ:MNKD) fell 6.65% in pre-market trading down to $3.
By Terry Chrisomalis RXi Pharmaceuticals Corp On August 31, 2015 RXi Pharmaceuticals Corp (NASDAQ:RXII) announced that the 30-day review period for its IND of RXI-109 …
In a research report released Thursday, Needham analyst Alan Carr reiterated a Buy rating on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a price …
Tesla Motors Inc (NASDAQ:TSLA) is up 2.56% in pre-market trading to $254.
